CHERYL MAY: Open Payments
NPI 1295304921 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $95 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $227 |
| Madrigal Pharmaceuticals | 1 | $142 |
| Novo Nordisk Inc | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: AIRSUPRA, REZDIFFRA, Ozempic, Kerendia, REXULTI.
Industry payments across IN — which companies pay providers there.
